| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 121.67B | 107.33B | 95.73B | 96.89B | 94.52B | 79.91B |
| Gross Profit | 53.25B | 50.45B | 45.63B | 40.80B | 37.47B | 34.63B |
| EBITDA | 23.82B | 23.29B | 21.42B | 19.29B | 17.56B | 16.85B |
| Net Income | 16.66B | 16.29B | 14.81B | 13.02B | 12.25B | 11.72B |
Balance Sheet | ||||||
| Total Assets | 86.79B | 83.38B | 74.21B | 69.46B | 57.86B | 55.10B |
| Cash, Cash Equivalents and Short-Term Investments | 16.91B | 21.52B | 12.01B | 13.38B | 12.18B | 15.07B |
| Total Debt | 6.99B | 5.54B | 5.28B | 6.08B | 4.79B | 5.10B |
| Total Liabilities | 44.73B | 40.72B | 32.52B | 29.90B | 23.81B | 22.52B |
| Stockholders Equity | 40.52B | 39.75B | 38.32B | 37.99B | 33.48B | 32.40B |
Cash Flow | ||||||
| Free Cash Flow | 5.59B | 12.02B | 12.83B | 12.37B | 8.84B | 19.26B |
| Operating Cash Flow | 7.01B | 13.63B | 14.36B | 14.19B | 10.16B | 20.68B |
| Investing Cash Flow | 6.00B | -6.21B | 1.76B | -8.65B | 4.25B | -9.38B |
| Financing Cash Flow | -12.03B | -6.49B | -15.42B | -5.60B | -12.90B | -10.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹1.03T | 76.67 | ― | 0.70% | 15.34% | 14.67% | |
70 Outperform | ₹497.43B | 43.58 | ― | 2.42% | -2.06% | -9.74% | |
69 Neutral | ₹988.61B | 54.57 | ― | 1.42% | 22.56% | 4.73% | |
66 Neutral | ₹739.81B | 39.88 | ― | 1.62% | 2.68% | 1.07% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ₹109.82B | 23.92 | ― | 1.92% | 5.24% | 9.79% | |
54 Neutral | ₹282.56B | 41.28 | ― | ― | 16.77% | 137.93% |